Durect Corp. Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Durect Corp. Stock
Our community identified positive and negative aspects for Durect Corp. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Durect Corp. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Durect Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Durect Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Durect Corp. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 8.590% | 26.964% | 33.347% | 29.131% | 35.546% | 163.162% | 23.939% |
| Evolus Inc | 0.000% | -15.439% | -18.305% | -49.792% | -11.560% | -32.113% | 57.208% |
| Champions Oncology Inc | 2.750% | 0.901% | 8.738% | 17.647% | -3.448% | 41.414% | -37.778% |
Comments
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat